| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2017 | Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients | Lee, MH; Huang, CF; Lai, HC; Lin, CY; Dai, CY; Liu, CJ; Wang, JH; Huang, JF; Su, WP; Yang, HC; Kee, KM; Yeh, ML; Chuang, PH; Hsu, SJ; Huang, CI; Kao, JT; Chen, CC; Chen, SH; Jeng, WJ; Yang, HI; Yuan, Y; Lu, SN; Sheen, IS; Liu, CH; Peng, CY; Kao, JH; Yu, ML; Chuang, WL; Chen, CJ | Scientific reports 7, 3718 | | | |
| 2010 | CYR61 regulates BMP-2-dependent osteoblast differentiation through {alpha}v{beta}3 integrin/ILK/ERK pathway. | Su, JL; Chiou, J; Tang, CH; Zhao, M; Tsai, CH; Chen, PS; Chang, YW; Chien, MS; Peng, CY; Hsiao, M; Kuo, ML; Yen, ML | J Biol Chem Oct 8; 285(41), 31325-31336. Cite 16 | | | |
| 2016 | Differences in hepatitis viral etiology of hepatocellular carcinoma in Taiwan and China | Chen, DS; Liaw, YF; Chen, CJ ; Wu, JC; Chuang, WL; Peng, CY; Chien, RN | Hepatology (Baltimore, Md.) 64(3), 1008-1009 | | | |
| 2006 | Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics. | Lee, TH; Tai, DI; Cheng, CJ; Sun, CS; Lin, CY; Sheu, MJ; Lee, WP; Peng, CY; Wang, AHJ ; Tsai, SL | Journal of biomedical science 13(1), 27-39 | | | |
| 2022 | Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine | Park, J; Le, AK; Tseng, TC; Yeh, ML; Jun, DW; Trinh, H; Wong, GLH; Chen, CH; Peng, CY; Kim, SE; Oh, H; Kwak, MS; Cheung, KS; Toyoda, H; Hsu, YC; Jeong, JY; Yoon, EL; Ungtrakul, T; Zhang, J; Xie, Q; Ahn, SB; Enomoto, M; Shim, JJ; Cunningham, C; Jeong, SW; Cho, YK; Ogawa, E; Huang, R; Lee, DH; Takahashi, H; Tsai, PC; Huang, CF; Dai, CY; Tseng, CH; Yasuda, S; Kozuka, R; Li, J; Wong, C; Wong, CC; Zhao, C; Hoang, J; Eguchi, Y; Wu, C; Tanaka, Y; Gane, E; Tanwandee, T; Cheung, R; Yuen, MF; Lee, HS; Yu, ML; Kao, JH; Yang, HI ; Nguyen, MH | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20(4), 874-885.e4 | | | |
| 2020 | Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy. | Yang, HI ; Yeh, ML; Wong, GL; Peng, CY; Chen, CH; Trinh, HN; Cheung, KS; Xie, Q; Su, TH; Kozuka, R; Lee, DH; Ogawa, E; Zhao, C; Ning, HB; Huang, R; Li, J; Zhang, JQ; Ide, T; Xing, H; Iwane, S; Takahashi, H; Wong, C; Wong, C; Lin, CH; Hoang, J; le, A; Henry, L; Toyoda, H; Ueno, Y; Gane, EJ; Eguchi, Y; Kurosaki, M; Wu, C; Liu, C; Shang, J; Furusyo, N; Enomoto, M; Kao, JH; Yuen, MF; Yu, ML; Nguyen, MH | The Journal of infectious diseases 221(3), 389-399 | | | |
| 2021 | Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines | Teng, W; Chang, TT; Yang, HI ; Peng, CY; Su, CW; Su, TH; Hu, TH; Yu, ML; Yang, HC; Wu, JC | Hepatology international 15, 1421-1430 | | | |
| 2019 | Taiwan consensus statement on the management of chronic hepatitis B. | Chien, RN; Kao, JH; Peng, CY; Chen, CH; Liu, CJ; Huang, YH; Hu, TH; Yang, HI ; Lu, SN; Ni, YH; Chuang, WL; Lee, CM; Wu, JC; Chen, PJ; Liaw, YF | JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 118(1 Pt 1), 7-38 | | | |
| 2018 | The human C-type lectin 18 is a potential biomarker in patients with chronic hepatitis B virus infection | Tsai, TY; Peng, CY; Yang, HI ; Huang, YL; Tao, MH ; Yuan, SS ; Lai, HC; Hsieh, SL | JOURNAL OF BIOMEDICAL SCIENCE 25, 59 | | | |
